Trending Now
Business
Goldman Sachs, Credit Suisse Battle With ‘Shock Exchange’ Over Teva
Generics drug giant Teva has been reeling since Mylan won approval to offer a generic version of blockbuster multiple sclerosis drug Copaxone. The drug...
Allergan: Botox Biosimilar From Mylan And Revance Sounds Ominous
Mylan (MYL) and Revance Therapeutics (RVNC) announced a global collaboration and license agreement to develop and commercialize a biosimilar for Allergan's (AGN) Botox:
Mylan N.V....
Lifestyle today
Entertainment
Powell Tells Congress Gradual Rate Hikes Are Needed
Last week Federal Reserve Chairman Jerome Powell submitted his semiannual monetary policy report to Congress. Mr. Powell convinced Congress the economy was not overheating,...
Biospecifics Technologies Will Send Endo To The Moon
Endo International (ENDP) remains one of the market's most frustrating, confounding stocks. The stock hit a high of over $18 in the second half...
LeBron Catches Jusuf Nurkic Lacking
There are likely a few sights that could send shivers down a professional athletes spine - Kareem Abdul Jabbar lining you up for...
A Predictor Of Recession Goes Haywire
Due to concerns over future economic growth and financial markets volatility, Federal Reserve Chairman Jerome Powell could end the balance sheet unwind fairly soon:
https://twitter.com/FinancialTimes/status/1100817623820980225
Volatility...
Federal Judge Clears The Deck For Landmark Opioid Deal
Two years ago President Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the opioid...
General Electric: Will Culp Whiff On 2 Key Questions?
General Electric (GE) reports quarterly earnings Thursday. Analysts expect revenue of $32.67 billion and eps of $0.22. A lot has changed over the past...
Kate From Uber: ‘Jameis Winston Groped Me’
The Tampa Bay Buccaneers' "Famous" Jameis Winston is in news again, despite the fact that he is not currently on the field. An Uber...
NPR’s Ailsa Chang Co-Signs Trump And The GE On Opioid Litigation
Opioid litigation that has dominated the 24-hour news cycle over the past four years appears to be coming to a head. This...























































































































